ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

Making Medicines Available at Reasonable Prices

The report of the task force on making life-saving drugs available at reasonable prices is sufficiently sanguine to the realities of the country, making it possibly the first official report which recognises competition does not work in the pharma formulations sector and that patients do not really have a choice in the matter like in other consumer segments. It asserts that price regulation should be on the basis of essentiality of the drug and strategic considerations about the impact of price control on the therapeutic class, rather than on market share and turnover. This is significant myth-breaking by official hammers.

Dear reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top